MatsukiyoCocokara & Co. (TYO:3088)
Japan
· Delayed Price · Currency is JPY 2,832.00
-4.50 (-0.16%)
At close: Dec 5, 2025
MatsukiyoCocokara & Co. Revenue
MatsukiyoCocokara & Co. had revenue of 275.45B JPY in the quarter ending September 30, 2025, with 3.56% growth. This brings the company's revenue in the last twelve months to 1.08T, up 4.28% year-over-year. In the fiscal year ending March 31, 2025, MatsukiyoCocokara & Co. had annual revenue of 1.06T with 3.82% growth.
Revenue (ttm)
1,084.99B
Revenue Growth
+4.28%
P/S Ratio
1.04
Revenue / Employee
85.08M
Employees
12,753
Market Cap
1,126.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,061.63B | 39.10B | 3.82% |
| Mar 31, 2024 | 1,022.53B | 71.28B | 7.49% |
| Mar 31, 2023 | 951.25B | 221.28B | 30.31% |
| Mar 31, 2022 | 729.97B | 173.06B | 31.08% |
| Mar 31, 2021 | 556.91B | -33.69B | -5.70% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |